We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+3.45%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$2.98B
AUM Growth
+$44.6M
Cap. Flow
-$43.5M
Cap. Flow %
-1.46%
Top 10 Hldgs %
17.88%
Holding
384
New
16
Increased
112
Reduced
199
Closed
11

Top Buys

Rank Stock Value
1
INGR icon
Ingredion
INGR
+$10.4M
2
KR icon
Kroger
KR
+$9.71M
3
BAC icon
Bank of America
BAC
+$9.14M
4
TSN icon
Tyson Foods
TSN
+$7.82M
5
NUE icon
Nucor
NUE
+$7.14M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$11.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$8.64M
3
SLB icon
SLB Ltd
SLB
+$7.93M
4
CCL icon
Carnival Corporation Ltd
CCL
+$6.08M
5
GLW icon
Corning
GLW
+$5.02M

Sector Composition

Rank Sector Weight
1 Financials 15.17%
2 Healthcare 11.66%
3 Technology 10.82%
4 Consumer Discretionary 10.35%
5 Industrials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEO icon
326
Diageo
DEO
$53.8B
$283K 0.01%
2,362
-49
-2% -$5.84K
NZF icon
327
Nuveen Municipal Credit Income Fund
NZF
$2.43B
$282K 0.01%
18,874
WCN
328
Waste Connections
WCN
$41.9B
$275K 0.01%
4,266
-1,350
-24% -$83.9K
VT icon
329
Vanguard Total World Stock ETF
VT
$81.2B
$271K 0.01%
4,012
BPL
330
DELISTED
Buckeye Partners, L.P.
BPL
$269K 0.01%
4,194
HUM icon
331
Humana
HUM
$46.5B
$268K 0.01%
1,113
-105
-9% -$23.8K
VRTX icon
332
Vertex Pharmaceuticals
VRTX
$135B
$264K 0.01%
2,050
-30
-1% -$3.61K
AZZ icon
333
AZZ Inc
AZZ
$4.53B
$259K 0.01%
4,636
HBI
334
DELISTED
Hanesbrands
HBI
$259K 0.01%
11,190
-50
-0.4% -$1.08K
AEE icon
335
Ameren
AEE
$29.7B
$251K 0.01%
4,600
+657
+17% +$36.5K
VER
336
DELISTED
VEREIT, Inc.
VER
$249K 0.01%
6,123
CSX icon
337
CSX Corp
CSX
$93.3B
$246K 0.01%
+13,548
New +$232K
TMO icon
338
Thermo Fisher Scientific
TMO
$220B
$246K 0.01%
1,407
-52
-4% -$8.73K
ATR icon
339
AptarGroup
ATR
$8.52B
$243K 0.01%
+2,800
New +$231K
GWW icon
340
W.W. Grainger
GWW
$60.7B
$237K 0.01%
1,310
CWB icon
341
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.6B
$235K 0.01%
4,743
+55
+1% +$2.69K
WEC icon
342
WEC Energy
WEC
$34.7B
$235K 0.01%
3,825
-1,696
-31% -$105K
TCBI icon
343
Texas Capital Bancshares
TCBI
$4.3B
$232K 0.01%
3,000
BBY icon
344
Best Buy
BBY
$17.4B
$228K 0.01%
+3,969
New +$212K
BWX icon
345
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$228K 0.01%
8,244
-2,180
-21% -$59.4K
DCI icon
346
Donaldson
DCI
$11.2B
$228K 0.01%
5,000
LAZ icon
347
Lazard
LAZ
$4.13B
$227K 0.01%
4,894
VCR icon
348
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$227K 0.01%
1,600
VBR icon
349
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
$224K 0.01%
1,822
-23
-1% -$2.81K
EXC icon
350
Exelon
EXC
$46.1B
$223K 0.01%
8,676

Similar funds

Cullen/Frost Bankers's Q2 2017 Portfolio in Review

As of Q2 2017, Cullen/Frost Bankers held 384 positions worth $2.98B, up 1.5% from $2.93B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cullen/Frost Bankers's Q2 2017 filing shows 16 new, 112 increased, 199 reduced and 11 closed positions. Its largest new stake was Ingredion: 87,222 shares worth $10.4M. The largest sale was CVS Health, an estimated $11.7M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

  • Cullen/Frost Bankers's largest Q2 2017 buy was Ingredion: 87,222 shares worth $10.4M.
  • Cullen/Frost Bankers added most to Kroger in Q2 2017, an estimated $9.71M increase.
  • Cullen/Frost Bankers's biggest Q2 2017 reduction was CVS Health, cutting an estimated $11.7M.
  • Cullen/Frost Bankers fully exited The WhiteWave Foods Company in Q2 2017, selling an estimated $4.89M.
  • Cullen/Frost Bankers's ten largest holdings make up 18% of its $2.98B portfolio in Q2 2017.
  • Cullen/Frost Bankers opened 16 new positions and closed 11 in Q2 2017.
  • Cullen/Frost Bankers's portfolio value rose 1.5% quarter-over-quarter to $2.98B.

Based on Cullen/Frost Bankers's 13F filing for Q2 2017, filed 31 Jul 2017.